This AI giant dominates the market, and despite its explosive growth, the stock might be cheaper than you think.

Fintel reports that on July 25, 2025, William Blair downgraded their outlook for Ameriprise Financial (NYSE:AMP) from ...

Eli Lilly and Novo Nordisk are currently the only drugmakers with FDA approved weight-loss medicines on the U.S. market.

William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.

Palo Alto Networks, Inc. (NASDAQ:PANW) is one of the best long term low volatility stocks to buy now. On July 16, William ...

Palantir Technologies Inc. (NASDAQ: PLTR) is one of the best 52-week high stocks to buy now. On July 21, the stock was a big ...

William Blair announced today that Robert D. Kendall has been named global head of the firm’s investment management business, responsible for the strategic direction of the business including all ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

The European Union’s health regulatory agency did not endorse approving Elevidys for ambulatory patients with Duchenne ...

He was preceded in death by sons William Blair III and Jordan Blair. Advertisement “He was a Renaissance man,” said Gregory Jordan, a nephew.